BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34175442)

  • 1. Clinical utility of whole-genome sequencing in precision oncology.
    Rosenquist R; Cuppen E; Buettner R; Caldas C; Dreau H; Elemento O; Frederix G; Grimmond S; Haferlach T; Jobanputra V; Meggendorfer M; Mullighan CG; Wordsworth S; Schuh A
    Semin Cancer Biol; 2022 Sep; 84():32-39. PubMed ID: 34175442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.
    Jobanputra V; Wrzeszczynski KO; Buttner R; Caldas C; Cuppen E; Grimmond S; Haferlach T; Mullighan C; Schuh A; Elemento O
    Semin Cancer Biol; 2022 Sep; 84():23-31. PubMed ID: 34256129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging sequencing-based tools for precision cancer medicine.
    Edsjö A; Gisselsson D; Staaf J; Holmquist L; Fioretos T; Cavelier L; Rosenquist R
    Mol Aspects Med; 2024 Apr; 96():101250. PubMed ID: 38330674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision diagnostics in cancer: Predict, prevent, and personalize.
    Crabtree JS; Miele L
    Prog Mol Biol Transl Sci; 2022; 190(1):39-56. PubMed ID: 36008001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on genomic-guided therapies for pediatric solid tumors.
    Tsui PC; Lee YF; Liu ZWY; Ip LRH; Piao W; Chiang AKS; Lui VWY
    Future Oncol; 2017 Jun; 13(15):1345-1358. PubMed ID: 28589766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision oncology in the age of integrative genomics.
    Kumar-Sinha C; Chinnaiyan AM
    Nat Biotechnol; 2018 Jan; 36(1):46-60. PubMed ID: 29319699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Genome-Driven Oncology.
    Hyman DM; Taylor BS; Baselga J
    Cell; 2017 Feb; 168(4):584-599. PubMed ID: 28187282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in precision therapy in pediatric oncology.
    O'Donohue T; Farouk Sait S; Glade Bender J
    Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
    Edsjö A; Russnes HG; Lehtiö J; Tamborero D; Hovig E; Stenzinger A; Rosenquist R;
    J Intern Med; 2024 Jun; 295(6):785-803. PubMed ID: 38698538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
    Tao JJ; Schram AM; Hyman DM
    Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput sequencing in clinical oncology: from past to present.
    Mery B; Vallard A; Rowinski E; Magne N
    Swiss Med Wkly; 2019 Mar; 149():w20057. PubMed ID: 30946479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
    De Mattos-Arruda L; Rodon J
    Oncologist; 2013; 18(11):1180-8. PubMed ID: 24136009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.
    Casolino R; Beer PA; Chakravarty D; Davis MB; Malapelle U; Mazzarella L; Normanno N; Pauli C; Subbiah V; Turnbull C; Westphalen CB; Biankin AV
    CA Cancer J Clin; 2024; 74(3):264-285. PubMed ID: 38174605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
    Le Tourneau C; Perret C; Hackshaw A; Blay JY; Nabholz C; Geissler J; Do T; von Meyenn M; Dienstmann R
    JCO Precis Oncol; 2022 Jul; 6():e2200019. PubMed ID: 35939770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
    Helland Å; Russnes HG; Fagereng GL; Al-Shibli K; Andersson Y; Berg T; Bjørge L; Blix E; Bjerkehagen B; Brabrand S; Cameron MG; Dalhaug A; Dietzel D; Dønnem T; Enerly E; Flobak Å; Fluge S; Gilje B; Gjertsen BT; Grønberg BH; Grønås K; Guren T; Hamre H; Haug Å; Heinrich D; Hjortland GO; Hovig E; Hovland R; Iversen AC; Janssen E; Kyte JA; von der Lippe Gythfeldt H; Lothe R; Lund JÅ; Meza-Zepeda L; Munthe-Kaas MC; Nguyen OTD; Niehusmann P; Nilsen H; Puco K; Ree AH; Riste TB; Semb K; Steinskog ESS; Stensvold A; Suhrke P; Tennøe Ø; Tjønnfjord GE; Vassbotn LJ; Aas E; Aasebø K; Tasken K; Smeland S
    J Transl Med; 2022 May; 20(1):225. PubMed ID: 35568909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic sequencing in cancer.
    Tuna M; Amos CI
    Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.